Rovelizumab, CAS 339086-79-2

Product Description: Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke[1].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]Qualls JE, et al. A double agent in cancer: stopping macrophages wounds tumors. Nat Med. 2010 Aug;16(8):863-4./[2]Jones R. Rovelizumab (ICOS Corp). IDrugs. 2000 Apr;3(4):442-6.

CAS Number: 339086-79-2

Molecular Weight: N/A

Compound Purity: 97.23

Research Area: Cardiovascular Disease

Solubility: H2O

Target: Integrin

• Artikelnummer: MEXHY-P99891-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99891-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated